How to test and define HRD positive population in ovarian cancer

Date 09 October 2016
Event ESMO 2016 Congress
Session Personalised medicine in gynaecological cancers
Topics Ovarian Cancer
Personalised Medicine
Presenter Iain McNeish
Authors I. McNeish
  • Wolfson Wohl Cancer Research Centre, University of Glasgow Beatson Institute for Cancer Research, G61 1QH - Glasgow/GB